Simulations Plus, Inc. is a healthcare technology company based in the United States. With an ESG risk rating score of 17.9, the company is assessed as low risk. Specializing in software development for pharmaceutical research and education, Simulations Plus also offers consulting and contract research services to the pharmaceutical industry. The company's operations are divided into software development and service provision segments, with a focus on generating revenue from software sales.